Siemens Healthineers Co-Leads EU Stroke Care Improvement Project
Siemens Healthineers is collaborating with over 20 industry and public partners, including seven leading stroke hospitals, to enhance stroke management across Europe. The five-year UMBRELLA project, with a total budget…
HCA Healthcare Donates $1 Million for Hurricane Helene Relief in North Carolina
HCA Healthcare, Inc. (NYSE: HCA), a leading healthcare provider in the U.S., has announced a $1 million donation to support Hurricane Helene relief efforts in North Carolina through community organizations.…
Aetna’s 2025 Medicare Plans Prioritize Key Member Health Needs
Aetna®, a CVS Health® company, has announced its 2025 Medicare products, focusing on essential benefits that enhance members’ overall health. The offerings include affordable Medicare Advantage (MA) plans featuring $0…
Elevance Health’s 2025 Medicare Advantage Plans Overview
Elevance Health (NYSE: ELV) has announced its affiliated health plans will offer flexible Medicare Advantage options with personalized supplemental benefits aimed at enhancing the overall health of nearly 40.3 million…
UnitedHealthcare Invests $335,000 to Boost Idaho Health Care Workforce and Access
UnitedHealthcare has announced a $335,000 funding initiative aimed at enhancing healthcare access in Idaho, particularly for underserved communities, including rural populations, individuals with chronic conditions, and seniors. “By expanding programs…
KalVista Pharmaceuticals Shares Sebetralstat Data at 2024 HAEi Forum
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) announced that it presented data demonstrating the effectiveness of sebetralstat in reducing anxiety during hereditary angioedema (HAE) attacks at the HAEi Global Angioedema Forum (GAF)…
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(C)(4)
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on innovative treatments for neurological diseases, announced the granting of inducement awards to three new employees. The Board’s Compensation Committee…
Kezar Life Sciences Puts Zetomipzomib IND for Lupus Nephritis on Clinical Hold
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology firm focused on developing innovative small molecules for immune-mediated diseases, has announced that its Investigational New Drug (IND) application for zetomipzomib,…
First Patient Enrolled in Phase I/IIa Trial for Lenti-HPV-07 Vaccine Against HPV-Induced Cancers
TheraVectys, a biotechnology firm focused on creating lentiviral vector-based vaccines and immunotherapies for infectious diseases and cancers, has announced the enrollment of the first patient in a Phase I/IIa clinical…
Medical Alert Monitoring Association Conference Highlights Innovations in Remote Care for Seniors
The Medical Alert Monitoring Association (MAMA) recently wrapped up its annual conference in Washington D.C. on September 24 and 25. The event gathered industry leaders, healthcare professionals, and advocates dedicated…
A2 Bio to Present EVEREST-1 Trial Data at SITC 2024
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company focused on developing first-in-class logic-gated cell therapies to selectively target tumor cells while protecting healthy cells, has announced that six…
Study Shows Kerecis Fish-Skin Outperforms in Diabetic Foot Ulcer Treatment
Kerecis, a leader in the use of fish skin and fatty acids for tissue regeneration, has announced the publication of significant study results in the New England Journal of Medicine…